HOME >> BIOLOGY >> NEWS
Research suggests possible marker, preventive treatment for preeclampsia

WINSTON-SALEM, N.C. - New research findings suggest a possible marker - and preventive treatment - for preeclampsia, the second leading cause of pre-term birth in the United States.

Researchers from Wake Forest University Baptist Medical Center (WFUBMC) in Winston-Salem, N.C., and the Pontificia University in Santiago, Chile, said levels of angiotensin-(1-7), a naturally occurring hormone that helps "brake" high blood pressure, increase during normal pregnancies and are low in pregnant women with preeclampsia. The findings were reported at a meeting of the American Heart Association's Council for High Blood Pressure Research.

"While the cause of preeclampsia is currently unknown, this research indicates a possible mechanism for the condition," said David Merrill, M.D., a specialist in obstetrics and maternal/fetal medicine at WFUBMC. "Additional research is needed to show if low levels of angiotensin-(1-7) early in a pregnancy can predict preeclampsia, and if levels can be altered to prevent the disorder."

Preeclampsia, which affects about 5 percent of pregnancies, is characterized by high blood pressure, fluid retention and protein in the urine. In severe cases, untreated preeclampsia can lead to fetal or maternal death. Currently, the only treatment for preeclampsia is pre-term delivery.

K. Bridget Brosnihan, Ph.D., hypertension researcher at WFUBMC, said these were the first studies of the role of angiotensin-(1-7) in pregnancy. The hormone, identified earlier by WFUBMC researchers, causes blood vessels to dilate and is believed to be the body's natural "braking system" against high blood pressure.

In one study, conducted by Brosnihan, Merrill and Michael Karoly, M.D., all of WFUMBC, researchers measured levels of angiotensin-(1-7) in blood samples from three groups of women. The hormone's levels increased by 50 percent in normal pregnancies compared to a non-pregnant control group. In pregnant women with preeclampsia, levels o
'"/>

Contact: Karen Richardson
krchrdsn@wfubmc.edu
336-716-4587
Wake Forest University Baptist Medical Center
24-Oct-2000


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
4. Researchers identify protein promoting vascular tumor growth
5. Researchers devise potent new tools to curb ivory poaching
6. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
7. Researchers ID chlorophyll-regulating gene
8. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
9. Research suggests new avenue for stopping, preventing colon cancer
10. Researchers develop fast track way to discover how cells are regulated
11. Research on carbohydrate metabolism receives historical recognition

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
(Date:4/13/2017)... , April 13, 2017 According to a new ... Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, ... IAM Market is expected to grow from USD 14.30 Billion in 2017 ... (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
Breaking Biology News(10 mins):
(Date:9/19/2017)... ... September 19, 2017 , ... Molecular Devices, LLC, a ... GmbH to launch the CloneSelect™ Single-Cell Printer™ in North America. This novel ... and provide visual documentation of monoclonality for use in cell line development. ...
(Date:9/18/2017)... 2017   Montrium , a growing leader in Electronic ... with a groundbreaking non-profit research organization, Multidisciplinary Association for Psychedelic ... MAPS ... PTSD ... Therapy Designation to MDMA for the treatment of Posttraumatic Stress Disorder ...
(Date:9/14/2017)... PA and London UK (PRWEB) , ... September ... ... will gather the most innovative minds in pharma and biotech at the third ... a two-day collaborative conference that brings together the world’s most progressive clinical research ...
(Date:9/14/2017)... ... 14, 2017 , ... AIM Global, the worldwide standards agency for AIDC and ... 2017 Case Study Competition for AIDC. The award is given to those in ... push the adoption of automated data collection systems further. The TRACTUS platform, by ...
Breaking Biology Technology:
Cached News: